Zhengye Biotechnology Holding (ZYBT) Debt to Equity (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) reported Debt to Equity of $0.24 for Q4 2025, up 7.26% year-over-year from $0.22 in Q4 2024, and up 1713.87% quarter-over-quarter from $0.01 in Q2 2025.

Zhengye Biotechnology Holding (ZYBT) Debt to Equity (2023 - 2025) Analysis & Trends

Zhengye Biotechnology Holding (ZYBT) has 3 years of Debt to Equity data on file, last reported at $0.24 in Q4 2025.

  • Debt to Equity for Q4 2025 came in at $0.24, up 7.26% year-over-year; the trailing twelve-month figure through Dec 2025 was $0.24 (up 7.26% YoY), and the FY2025 annual result was $0.23, down 15.92% from the prior year.
  • Debt to Equity rose to $0.24 in Q4 2025 per ZYBT's latest filing, from $0.01 in the prior quarter.
  • Over five years, Debt to Equity peaked at $0.24 in Q4 2025 and troughed at $0.01 in Q2 2025.
  • A 3-year average of $0.18 and a median of $0.23 in 2023 frame the typical range for Debt to Equity.
  • The sharpest annual moves came in 2024 and 2025: Debt to Equity fell 4.97% in 2024, then climbed 7.26% in 2025.
  • A 3-year view of Debt to Equity shows it stood at $0.24 in 2023, then declined by 4.97% to $0.22 in 2024, then gained by 7.26% to $0.24 in 2025.
  • Business Quant data shows ZYBT's Debt to Equity at $0.24 in Q4 2025, $0.01 in Q2 2025, and $0.22 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 2.02
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 2.80
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 0.01
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 0.61
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 0.86
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 0.47
10 Zhengye Biotechnology Holding 5.49 Mn 6.20 Mn - 0.24

Historic Data

Download Data
DateValue
Dec 31, 2025 0.24
Jun 30, 2025 0.01
Dec 31, 2024 0.22
Dec 31, 2023 0.24